About Us

Ali Shokoohmand

Ali Shokoohmand


  • Postdoctoral Research Fellow, APCRC-Q
  • Member, IHBI

Contact Details

+614504 45848
Linkedin profile

Related websites and profiles



  • Doctor of Philosophy (PhD), Cell/Cellular and Molecular biology, Queensland University of Technology (QUT), July 2015
  • Master of Biotechnology, Queensland University of Technology (QUT), 2010 – 2011 (Not completed)
  • Bachelor of Biotechnology, Griffith University, 2008 -2010
  • Bachelor of Applied Science (Microbiology and Cell/Cellular Biology), 2001 – 2006


Dr Ali Shokoohmand is early career research fellow at Australian Prostate Cancer Research Centre-Queensland (APCRC-Q) at Translational Research Institute (TRI), QUT, supporting tumor microenvironment research with a Movember Revolutionary Team Award (MRTA) that addresses advanced prostate cancer research. His research focuses on development and validation in vitro engineering of human-derived three dimensional (3D) prostate cancer tumour models to investigate androgen targeted therapies and rationalised co-targeting agents, and to identify novel molecular mechanisms underlying cellular and micro-environmental regulation of prostate cancer development and progression at different stages. 

Awards and grants



Merit Award, 10th World Biomaterials Congress (WBC), Canada


Travel Award, Gordon Research Conferences (GRC), IGF Society conference, USA


 Dean's Merit Award, Queensland University of Technology



Institute of Health and Biomedical education Early Career research Grant

Identification of extracellular matrix-growth factor interactions and their mechanism of action in cancer progression

Mentors: DW Hutmacher, D Loessner, B Hollier

Research interests

Cell/Cellular and Molecular Biology, Cancer biology, Biomaterials of cancer

Current research projects

In vitro engineering of the human prostate tumor microenvironment

Top publications

Shokoohmand A, Loessner D, Holzapfel BM, Wagner F, Baldwin J, Rockstroh A, Magdolen V, Clements JA and Hutmacher DW. A bioengineered 3D approach to mimic the tumor-stroma microenvironment of ovarian cancer. Front. Bioeng. Biotechnol. 2016; Conference Abstract: 10th World Biomaterials Congress. 2016; doi: 10.3389/conf.FBIOE.2016.01.02987.

 Muerza-Cascante ML, Shokoohmand A, Khosrotehrani K, Haylock D, Dalton PD, Hutmacher DW, & Loessner D. Endosteal-like extracellular matrix expression on melt electrospun written scaffolds. Accepted to Acta Biomaterialia. 2016.

 Kashyap AS, Shooter GK, Shokoohmand A, McGovern J, Sivaramakrishnan M, Croll TI, Cane G, Leavesley D I, Söderberg O, Upton Z, & Hollier, B.G., 2016. Antagonists of IGF: Vitronectin interactions inhibit IGF-I-induced breast cancer cell functions. Molecular cancer therapeutics. 2016; doi: 10.1158/1535-7163.MCT-15-0907.

Dargaville TR, Hollier BG, Shokoohmand A, & Hoogenboom R. Poly (2-oxazoline) hydrogels as next generation three-dimensional cell supports. Cell adhesion & migration. 2014; 8(2), 88-93.

Leavesley, DI, Kashyap AS, Croll T., Sivaramakrishnan M, Shokoohmand A, Hollier BG, & Upton Z. Vitronectin—Master controller or micromanager?. IUBMB life. 2013; 65(10), 807-818.


Dr Daniela Loessner

Dr Laura Bray

Dr Abbas Shafiee

Dr Tony Parker

Dr Pawel Sadowski

Dr Elena Juan Pardo

Professional memberships and associations

2011 – present

Australian Society of Medical Research (ASMR)